Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

FOUND: Empyrean - You Need To See This

You can get Enshrouded Twitch Drops today, tomorrow, and next month—even for that one outfit you missed years ago

Nothing stands between me and a fluffy hoodie.

PC Gamer · Jan 23

Side Gig Workers Could Soon Be Without Medicaid: What You Need To Know

New Medicaid rules could leave side gig workers uninsured—learn who’s at risk, what’s changing and how to protect your healthcare coverage.

GOBankingRates · Sep 7, 2025

The 38 Best Romantasy Books to Read in 2026

Here's what to read when you've devoured the 'ACOTAR' and 'Empyrean' series.

Marie Claire · Feb 26, 2025

From analysis to the latest developments in health,
read the most diverse news in one place.

Empyrean Technology gives control to CEC after U.S. blacklisting — China’s top developer of chip design systems hands reins to state-owned firm

Empyrean Technology, the world's 4th-largest EDA (electronic design automation) firm, has given control of the company to state-owned China Electronics Corporation following blacklisting by the U.S. government's Entity List.

Tom’s Hardware · Dec 10, 2024

Months after completing a major project, leading Chinese chip development software firm cuts half of workforce: Report

X-Epic fires 200 employees just months after hitting major milestone with chip design tools.

Tom’s Hardware · Jul 12, 2024

Meze Audio Empyrean II are luxurious, high-end headphones that offer a "gateway to sonic paradise"

Meze Audio is back with a sequel to its flagship planar magnetic headphones, with improved driver performance and two sets of earpuds for a high-end price.

What Hi-Fi? · Nov 9, 2023

Meze Audio’s new art deco planar magnetic headphones sound like an audiophile’s dream

These gorgeous looking planar magnetics promise to deliver headphone heaven thanks to their innovative hybrid drivers.

TechRadar · Nov 8, 2023

Read news from The Economist, FT, and more,
with one subscription

Engineering Psychedelics: $22M Pool For Clinical Trials Of Compounds Targeting CNS Disorders

NYC and Cambridge-based Empyrean Neuroscience Inc. is a new genetic engineering company developing neuroactive compounds for neuropsychiatric and neurological disorders launching with a $22 million Series A financing.

Benzinga · Oct 19, 2022

Sensus Healthcare Offloads Sculptura Assets To Focus On Core Dermatology Offerings

Sensus Healthcare Inc (NASDAQ:SRTS) sold its Sculptura assets to Empyrean Medical Systems for $15 million in cash. The sale included an inventory of Sculptura systems and parts, in addition to all related intellectual property. The Sculptura system provides targeted Directional Anisotropic Radiation Therapy (ART) and brachytherapy utilizing proprietary, state-of-the-art 3D Beam Sculpting to treat…

Benzinga · Mar 2, 2022

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.